1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Impax Labs/Global

Anonymous board for Impax Labs/Global


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    3
    Views:
    1,562
  2. anonymous
    Replies:
    3
    Views:
    1,756
  3. anonymous
    Replies:
    2
    Views:
    1,348
  4. anonymous
    Replies:
    0
    Views:
    634
  5. Anonymous
    Replies:
    16
    Views:
    5,655
  6. anonymous
    Replies:
    21
    Views:
    7,859
  7. anonymous
    Replies:
    5
    Views:
    2,330
  8. AR60M
    Replies:
    0
    Views:
    626
  9. anonymous
    Replies:
    2
    Views:
    4,016
  10. anonymous
    Replies:
    1
    Views:
    1,801
  11. anonymous
    Replies:
    0
    Views:
    1,101
  12. anonymous
    Replies:
    5
    Views:
    1,811
  13. anonymous
    Replies:
    1
    Views:
    2,308
  14. anonymous
    Replies:
    5
    Views:
    2,947
  15. anonymous
    Replies:
    10
    Views:
    4,830
  16. anonymous
    Replies:
    3
    Views:
    2,286
  17. anonymous
    Replies:
    4
    Views:
    3,070
  18. anonymous
    Replies:
    0
    Views:
    1,841
  19. RobertPhillips900
    Replies:
    1
    Views:
    1,498
  20. anonymous
    Replies:
    15
    Views:
    8,467

Thread Display Options

Loading...